Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hillerød – page 12

1 196 clinical trials in Hillerød, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hillerød at a glance
1 196
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 196 trials in Hillerød

Open in trial search

Endometrial cancer+2

Recruiting

A study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel
  • Sponsor:Genmab A/S

A Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Pfizer Inc.

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Evaluating the efficacy of pirtobrutinib and epcoritamab in patients with untreated Richter transformation of chronic lymphocytic leukemia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:University Of Cologne

Hepatic cancer

Recruiting

Evaluating the use of technetium (99mTc) galactosyl serum albumin to predict complications in patients undergoing surgery for liver tumors

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:99mTc-GSA
  • Sponsor:Region Hovedstaden

Glioma

Recruiting

A study of ulixertinib, tovorafenib, and vinblastine sulfate for children with progressive, relapsed, or refractory low-grade glioma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Tovorafenib
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Using glucagon and automated insulin delivery to prevent low blood sugar during exercise in adults with type 1 diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dasiglucagon
  • Sponsor:Steno Diabetes Center Copenhagen

A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Region Hovedstaden

A study of progesterone after letrozole treatment for women with infertility undergoing intrauterine insemination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Progesterone
  • Sponsor:Aarhus University Hospital

Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Glimepiride
  • Sponsor:Steno Diabetes Center Copenhagen

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Elranatamab
  • Sponsor:Vastra Gotalandsregionen

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD5148
  • Sponsor:AstraZeneca AB

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hillerød

What the registry says about research in the country

01 Gastroenterology Research

Ongoing clinical trials focusing on inflammatory bowel diseases, particularly investigating new treatments for Crohn's Disease and Ulcerative Colitis. Studies are evaluating the effectiveness of oral medications and biological therapies for managing moderate to severe cases.

  • Treatment optimization studies
  • Long-term disease management
  • Bowel wall healing assessment

Advanced therapeutic approaches aim to improve patient outcomes and quality of life.

02 Metabolic Disorders

Research initiatives targeting obesity and type 2 diabetes, with trials exploring innovative treatments combining medication with lifestyle modifications. Special focus on investigating new therapies for patients with concurrent weight management needs.

  • Weight management protocols
  • Diabetes control strategies
  • Combined therapeutic approaches

Studies aim to improve metabolic health outcomes through targeted interventions.

03 Cardiovascular Studies

Innovative research focusing on heart failure prevention and management of atrial fibrillation. Clinical trials are evaluating new medications and therapeutic combinations to reduce cardiovascular risks and improve patient outcomes.

  • Preventive cardiology
  • Stroke prevention
  • Cardiac treatment optimization

Advanced approaches in cardiovascular disease management and prevention.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.